ANIX
Anixa Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.07
+0.66%Next report
Analyst consensus
- Next report date
- Sep 9, 2026
- EPS estimate
- -$0.08
- Revenue estimate
- —
Latest reported
- Last report date
- Jun 10, 2026
- EPS actual
- -$0.07
- EPS estimate
- -$0.10
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +20.0%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Sep 9, 2026